A popular anti-aging drug combo may come with a disturbing downside: brain damage. Credit: Shutterstock A drug combination widely studied for its anti-aging potential may have a serious downside. Researchers at the University of Connecticut report that the treatment caused significant brain damage in mice, raising concerns about its growing use in longevity research and off-label anti-aging therapies. The findings, published in PNAS , showed that the drug pairing dasatinib+quercetin (D+Q)